A sulfonamide polymer with high molecular weight and high biological safety and its preparation method
By using green low-toxic bismuth catalysts in the field of vascular embolization, the problems of insufficient polymer molecular weight and catalyst toxicity in the prior art have been solved, and the improvement of high biosafety and strength has been achieved, and the expansion of the Application prospects in the field of vascular embolism.
Patent Information
- Application Number
- CN202410071903.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-01-18
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-01-18
AI Technical Summary
The existing pH-responsive liquid embolizers are limited in the field of vascular embolization. The strength is insufficient due to the small molecular weight of the polymer and the high toxicity of the catalysts used, which limits their biomedical applications.
The coupling reaction of green and low-toxic bismuth catalysts is used to perform a coupling reaction in polyethylene glycol and sulfonamide compounds to synthesize high molecular weight pH-responsive sulfonamide polymers, overcome the toxicity problem of traditional tin catalysts, and improve the synthesis route and conditions. The strength of the polymer.
The prepared high molecular weight polymer has high biosafety and strength, can show great application prospects in the field of vascular embolization, and it also shows continuous strip shapes in in vitro embolization simulation tests and is not easily dispersed, and the strength is obtained. Significant improvement.
Smart Images

Figure CN117887031B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the fields of biomedical polymer technology and interventional embolization technology, and in particular to a method for preparing a novel medical polymer material, which is mainly used for realizing effective vascular interventional embolization. Background Art
[0002] Vascular embolization is a method of achieving treatment by implanting embolic materials in blood vessels and blocking blood flow. Liquid embolization mainly uses microcatheters to inject liquid embolic materials into specific parts, which then undergo phase changes in the blood vessels, blocking blood flow to achieve specific treatment purposes.
[0003] Liquid embolic agents can be divided into three types according to their response mechanisms: solvent precipitation type, temperature response type, and pH response type. Among them, pH response type liquid embolic agents will only trigger their phase change after contact with blood and pH environment changes, thus avoiding the risks of tube blockage, reflux, and accidental embolism.
[0004] Sulfonamide polymers prepared with sulfadimethoxine as raw material are widely used in pH-responsive hydrogels. When the pH drops below the pKa (7.4) of the compound, the sulfonamide polymer undergoes a deionization process, and the macroscopic manifestation is that the hydrogel undergoes a phase change and solidifies. However, this type of polymer generally has the following problems: 1) The molecular weight of the polymer material is too small. Existing studies have shown that the molecular weight of this type of polymer is generally low (3000-30000). This will result in insufficient strength of the hydrogel after response, and it can only be used for the development and use of subcutaneous sustained-release preparations, but cannot be used in the field of vascular embolism, especially in arterial blood vessels with large blood flow and rich blood supply tumor applications. 2) Cytotoxicity problem. Most of these polymerization reactions use dibutyltin dilaurate as a catalyst, which has a high toxicity, greatly limiting its application in biomedicine.
[0005] Bismuth catalyst is a green and low-toxic polyurethane catalyst, which is used for the catalytic synthesis of polyurethane resins, adhesives, coatings, elastomers and other fields. However, so far, there is no relevant literature reporting the use of bismuth catalysts for the synthesis of sulfadimethoxine polymers. Therefore, it is of great significance to use green and low-toxic bismuth catalysts for the synthesis of this polymer. Summary of the invention
[0006] In view of the defects of the prior art, the present invention provides a method for preparing a high-molecular-weight and highly biosafe sulfonamide polymer to obtain a novel pH-responsive vascular embolization medical polymer material.
[0007] The technical scheme for achieving the above purpose is as follows: polyethylene glycol and sulfonamide compounds are used as raw materials, and are coupled with hexamethylene diisocyanate under the catalysis of a green and non-toxic bismuth catalyst to finally obtain a polyethylene glycol-sulfonamide copolymer. The polymerization method uses a new low-toxic bismuth catalyst to overcome the toxicity problem of traditional tin catalysts. At the same time, the method can prepare high-molecular-weight polymers, and the latter's strength is greatly improved, so that it shows great application prospects in the field of vascular embolism.
[0008] Specifically, polyethylene glycol, sulfonamide intermediate, and hexamethylene diisocyanate are mixed in a solvent N, N-dimethylformamide (according to a material-liquid ratio of 0.1-1 g / ml, i.e., the total mass of polyethylene glycol, sulfonamide intermediate, and hexamethylene diisocyanate to the solvent) according to a certain molar ratio (1:1-7:2-8, and the sum of the molar amounts of hydroxyl groups in polyethylene glycol and sulfonamide intermediate is equal to the molar amount of NCO in hexamethylene diisocyanate), and a bismuth catalyst of 0.5-1% (compared to all materials) is added, and the reaction is carried out under anhydrous and oxygen-free conditions at 60-80°C for 3-6 hours; then, the mixture is purified by a tetrahydrofuran / tert-butyl methyl ether mixed system, and after drying, a high molecular weight and high biosafety pH-responsive sulfonamide polymer is obtained. During the purification process, the product is precipitated by tert-butyl methyl ether, and the product is dissolved by tetrahydrofuran. In certain embodiments of the present invention, the amount of tetrahydrofuran is 1-5 times the equivalent of the reaction solution, and the amount of tert-butyl methyl ether is 1-5 times the equivalent of the reaction solution.
[0009] The sulfonamide intermediates described in the present application are a class of compounds having a benzenesulfonamide structure, including but not limited to the sulfonamide intermediates of the following structural formulas as indicated in the examples of the present application:
[0010]
[0011] in,
[0012] XNH,O
[0013]
[0014] The synthetic route of the polymer is as follows:
[0015]
[0016] For this sulfonamide intermediate, it can be prepared by the following method:
[0017] i) reacting the amino group or hydroxyl group of the raw material A with acryloyl chloride to generate C having an amide bond or an ester bond; in the reaction process, the acid binding agent is one of sodium hydroxide, potassium hydroxide, triethylamine, sodium carbonate, potassium carbonate, and sodium bicarbonate; the reaction solvent is DMF, chloroform, tetrahydrofuran, dichloromethane, or a mixture of water and acetone; the reaction temperature is -20-10°C and the reaction time is 8-24h.
[0018] ii) a click reaction between the double bond of C having an amide bond or an ester bond and the thiol group of the raw material D to obtain a sulfonamide intermediate; in the reaction, triethylamine is used as a catalyst, the reaction solvent is DMF, chloroform, tetrahydrofuran or dichloromethane, the reaction temperature is 0-25° C., and the reaction time is 8-24 h.
[0019] The reaction route is as follows:
[0020]
[0021] In the present application, the drying conditions of the purified product are: the oven temperature is from room temperature to 40°C, and the drying time is 6-24 hours.
[0022] The bismuth catalyst used in the present application includes but is not limited to: bismuth neodecanoate and bismuth isooctanoate.
[0023] Before the catalytic reaction of the present application, the polyethylene glycol and sulfonamide intermediates may be subjected to a dehydration treatment. The dehydration method includes but is not limited to dehydration by decompression with a vacuum pump at a certain temperature. The dehydration temperature is 80-100° C. and the dehydration time is 0.5-2 h.
[0024] The beneficial effects of the present invention are: the present invention adopts a new type of low-toxic bismuth catalyst to overcome the toxicity problem of traditional tin catalysts. The number average molecular weight of the polymer prepared by the present invention is between 15-20w, and the weight average molecular weight is between 25-30w, which is much larger than the polymers studied in the prior art. The solution of the polymer of the present invention will not be dispersed in the in vitro embolism simulation test, presenting a continuous strip shape, and agglomerate together after shaking, and the strength is greatly improved. Figure 6 ]. In summary, the polymer prepared by the present invention shows great application prospects in the field of vascular embolism. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 The compound E1 prepared in Example 1 of the present invention 1 H NMR spectra;
[0026] Figure 2 The compound E2 prepared in Example 2 of the present invention 1 H NMR spectra;
[0027] Figure 3The compound C3 prepared in Example 3 of the present invention 1 H NMR spectra;
[0028] Figure 4 The compound E4 prepared in Example 4 of the present invention 1 H NMR spectra;
[0029] Figure 5 The compound H4 prepared in Example 7 of the present invention 1 H NMR spectra;
[0030] Figure 6 This is a photograph of the solution of compound H4 prepared in Example 7 of the present invention after responding to PBS;
[0031] Figure 7 This is a graph showing the cytotoxicity results of the polymer H4 of the present invention. DETAILED DESCRIPTION
[0032] The present invention will be further described below in conjunction with the embodiments.
[0033] Example 1
[0034]
[0035] Synthesis of compound C1: In a 1L three-necked flask with a stirrer and a thermometer, add 100.0g of the starting compound A1 and 200mL of THF, stir, and cool to 0-5°C. Add 42.5g of TEA. Add 38.0g of acryloyl chloride (dissolved in 200mL of DCM) dropwise, and the mixture is dripped after 1 hour. After the dripping is completed, stir at 0-5°C for 15 minutes, remove the ice bath, and naturally warm to room temperature. Continue the reaction for 2 hours before stopping the reaction. After silica gel filtration, concentrate to obtain 80.0g of crude product C1.
[0036] Synthesis of sulfonamide intermediate E1: In a 1L three-necked flask with a stirrer and a thermometer, add 80.0g of sulfonamide intermediate C1 and 300mL of DCM, stir, and cool to 0-5°C. Add 0.26g of TEA. Add 328.1g of thioglycerol (dissolved in 100mL of DCM) dropwise, and the mixture is dripped after 15 minutes. After the dripping is completed, stir at 0-5°C for 15 minutes, remove the ice bath, and naturally warm to room temperature. Continue the reaction for 5 hours and then stop the reaction. After removing the solvent by rotary evaporation, column chromatography obtains 65.2g of an oily substance.
[0037] Example 2
[0038]
[0039] Synthesis of compound C2: In a 250mL three-necked flask with a stirrer and a thermometer, add 22.8g of compound A2, 4.4g of NaOH, 100mL of water and 50mL of acetone, stir, and cool to 0-5°C. Add 9.9g of acryloyl chloride (dissolved in 50mL of acetone) dropwise, and the dripping is completed after 30min. After the dripping is completed, stir at 0-5°C for 15min, remove the ice bath, and naturally warm to room temperature. Continue the reaction for 3h and then stop the reaction. Concentrate, add 100mL of water, and filter the solid precipitation. Slurry the solid with ethanol for 3h. Dry to obtain 25g of the product.
[0040] Synthesis of sulfonamide intermediate E2: In a 250mL three-necked flask with a stirrer and a thermometer, add 25.0g of compound C2 and 100mL of DMF, stir, and cool to 10°C. Add 0.09g of TEA. Add 10.4g of thioglycerol (dissolved in 20mL of DMF) dropwise, and the mixture is dripped after 15 minutes. After the dripping is completed, remove the ice bath, naturally warm to room temperature, and continue the reaction for 12 hours before stopping the reaction. After removing the solvent by rotary evaporation, column chromatography obtains 28.0g of a white solid.
[0041] Example 3
[0042]
[0043] Synthesis of compound C3: In a 100mL three-necked flask with stirring and a thermometer, add 2.5g of compound A3, 1.1g of sodium carbonate, 4mL of water and 15mL of THF, stir, and cool to 0-5°C. Add 1g of acryloyl chloride (dissolved in 5mL of THF) dropwise, and the mixture is added after 5 minutes. After the addition is completed, stir at 0-5°C for 15 minutes, remove the ice bath, and naturally warm to room temperature. Continue the reaction for 3 hours and then stop the reaction. Concentrate, add 10ml of water, and filter the precipitated solid. Slurry the solid with water for 3 hours. Dry to obtain 2.5g of the product.
[0044] Synthesis of sulfonamide intermediate E3: In a 100mL three-necked flask with a stirrer and a thermometer, add 1.0g of compound C3 and 5mL of DMF, stir, and cool to 10°C. Add 0.003g of TEA. Add 0.4g of thioglycerol (dissolved in 5mL of DMF) dropwise, and the mixture is dripped after 1 minute. After the dripping is completed, remove the ice bath, naturally warm to room temperature, and continue the reaction for 12 hours before stopping the reaction. After rotary evaporation to remove the solvent, column chromatography obtains 1.2g of white solid.
[0045] Example 4
[0046]
[0047] Synthesis of compound C4: In a 500mL three-necked flask with stirring and a thermometer, add 27.8g of compound A4, 4.4g of NaOH, 150mL of water and 100mL of acetone, stir, and cool to 0-5°C. Add 9.9g of acryloyl chloride (dissolved in 50mL of acetone) dropwise, and drip completely after 30min. After dripping, stir at 0-5°C for 15min, remove the ice bath, naturally warm to room temperature, continue the reaction for 3h, and then stop the reaction. Concentrate, add 100mL of water, and filter the solid. The aqueous phase is extracted three times with DCM / MeOH=10:1 and concentrated to a solid. Combine the solids and dry to obtain 26.5g of the product.
[0048] Synthesis of sulfonamide intermediate E4: In a 250mL three-necked flask with a stirrer and a thermometer, add 20.0g C4 and 100mL DMF, stir, and cool to 10°C. Add 0.06g TEA. Add 7.1g acryloyl chloride (dissolved in 20mL DCM) dropwise, and the mixture is finished after 15 minutes. After the addition, remove the ice bath, naturally warm to room temperature, and continue the reaction for 12 hours before stopping the reaction. After removing the solvent by rotary evaporation, column chromatography obtains 22.0g of white solid.
[0049] Example 5
[0050] Preparation of polymer H1: Add 1.03g polyethylene glycol (Mn=1500) to a 100mL reaction bottle with stirring, and use a vacuum oil pump to dehydrate the polyethylene glycol at 80°C for 1h. Add 1.92g sulfonamide intermediate E1 to the above reaction bottle under nitrogen protection, and continue to dehydrate under vacuum for 0.5h at a temperature of 80°C. Add 10mL N,N-dimethylformamide to dissolve the reactants under nitrogen protection, continue to add 0.111g bismuth isooctanoate catalyst, and 0.90g hexamethylene diisocyanate, and react at 60°C for 3h. Stop the reaction, cool to room temperature, and precipitate the polymer with 50ml tert-butyl methyl ether. Then add 20mL tetrahydrofuran to dissolve the polymer, and add 50ml tert-butyl methyl ether dropwise to precipitate the polymer; after purification, 2.4g of polymer is obtained.
[0051] Example 6
[0052]
[0053] Preparation of polymer H2: Add 1.03g polyethylene glycol (Mn=1500) to a 100mL reaction bottle with stirring, and use a vacuum oil pump to dehydrate the polyethylene glycol at 80°C for 1h. Add 0.26g sulfonamide intermediate E2 to the above reaction bottle under nitrogen protection, and continue to dehydrate under vacuum for 0.5h at a temperature of 80°C. Add 2.5mL N,N-dimethylformamide to dissolve the reactants under nitrogen protection, continue to add 0.028g bismuth neodecanoate catalyst, and 0.224g hexamethylene diisocyanate, and react at 60°C for 3h. Stop the reaction, cool to room temperature, and precipitate the polymer with 12.5ml tert-butyl methyl ether. Then add 12.5mL tetrahydrofuran to dissolve the polymer, and add 12.5ml tert-butyl methyl ether dropwise to precipitate the polymer; after purification, 2.2g of polymer is obtained.
[0054] Example 7
[0055] Preparation of polymer H4: Add 2.58g of polyethylene glycol (Mn=1500) to a 100mL reaction bottle with stirring, and remove water under vacuum at 80°C for 1h. Add 5.14g of sulfonamide intermediate E4 under nitrogen protection, and continue to remove water at 80°C for 0.5h. Add 25mL of N,N-dimethylformamide to dissolve the reactants under nitrogen protection, add 0.278g of bismuth neodecanoate and 2.24g of hexamethylene diisocyanate, and react at 80°C for 6h. Cool to room temperature and precipitate the polymer with 125ml of tert-butyl methyl ether. Then add 25mL of tetrahydrofuran to dissolve the polymer, and add 125ml of tert-butyl methyl ether dropwise to precipitate the polymer; after purification, 6.2g of polymer is obtained.
[0056] The polymers obtained in Examples 5 to 7 were characterized by gel permeation chromatography (GPC) using narrow distribution polyethylene glycol as a standard. The results are shown in Table 1. The molecular weight of the polymers described in Examples 5 to 7 reached more than 20w (Mw), which is much higher than the molecular weight of the polymers in the literature.
[0057] Table 1 Example 6 GPC data
[0058] polymer Mn M PDI Example 5 14.7w 21.7w 1.47 Example 6 14.4w 21.3w 1.42 Example 7 14.1w 20.9w 1.33
[0059] 300 mg of the sample of Example 6 was taken and extracted with 3 mL of culture medium for 24 h to obtain an extract. After L929 cells were plated, different concentrations of extracts were then added to a 96-well plate and incubated with the cells for 24 h. The culture medium was then aspirated, and a CCK8 detection kit was added to detect cell viability. The absorbance value at 450 nm was read with an ELISA reader and calculated to obtain the relative cell viability. The results are as follows: Figure 7 As shown, it was found that the cell survival rate was above 70% after 24 hours of co-culture with 0.1 g / mL of the extract.
[0060] Take 10mL of New Zealand rabbit blood and place it in a heparin anticoagulant tube, and use it after diluting it with physiological saline. The sample of Example 6 was extracted for 24h at 0.1g / mL (extraction medium: physiological saline), and 10mL of the extract was added to the test tube. 10mL of physiological saline and distilled water were taken as negative control and positive control, and the sample tube was placed in a 37°C constant temperature water bath for incubation for 30min. According to 0.2mL of diluted blood / 10mL of test sample, the diluted blood was added to the test tube and gently shaken, and continued to incubate in a 37°C constant temperature water bath for 60min. After centrifugation with an 800g centrifuge for 5min, the supernatant was taken to test its absorbance at 545nm, and the hemolysis rate was calculated. The results show that the hemolysis rate of the polymer obtained in Example 6 is 1.2% (less than 5%), indicating that the material does not produce hemolysis.
Claims
1. A method for preparing a high molecular weight and highly biosafe sulfonamide polymer, characterized in that: Polyethylene glycol and sulfonamide compounds are used as raw materials, and coupled with hexamethylene diisocyanate under the catalysis of a bismuth catalyst to obtain a polyethylene glycol-sulfonamide copolymer; The structural formula of sulfonamide compounds is: in, X=NH,O The molar ratio of polyethylene glycol, sulfonamide compound and hexamethylene diisocyanate is 1:1-7:2-8, and the sum of the molar amounts of hydroxyl groups in polyethylene glycol and sulfonamide intermediate is equal to the molar amount of NCO in hexamethylene diisocyanate; The molar content of the bismuth catalyst is 0.5 to 1% of the total amount of the reactants; The catalytic reaction is carried out under anhydrous and oxygen-free conditions at 60-80° C., and the reaction time is 3-6 hours.
2. The method according to claim 1, characterized in that Polyethylene glycol, sulfonamide compounds and hexamethylene diisocyanate are mixed in a solvent N,N-dimethylformamide at a material-liquid ratio of 0.1-1 g / mL.
3. The method according to claim 1, characterized in that Bismuth catalysts include, but are not limited to, bismuth neodecanoate and bismuth isooctanoate.
4. The method according to claim 1, characterized in that: The product obtained after the catalytic reaction is purified using a tetrahydrofuran / tert-butyl methyl ether system. Specifically, tert-butyl methyl ether is used to precipitate the product, and tetrahydrofuran is used to dissolve the product.
5. The sulfonamide polymer prepared by the method as claimed in claim 1.
Citation Information
Cited By
Preparation method of sulfonamide intermediates shared by broad-spectrum veterinary drugs and human drugs
CN120623112A
Preparation method of sulfonamide intermediates for use in broad-spectrum veterinary and human drugs
CN120623112B
